BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37107122)

  • 1. Phentolamine Significantly Enhances Macrolide Antibiotic Antibacterial Activity against MDR Gram-Negative Bacteria.
    Cui ZH; He HL; Zheng ZJ; Yuan ZQ; Chen Y; Huang XY; Ren H; Zhou YF; Zhao DH; Fang LX; Yu Y; Liu YH; Liao XP; Sun J
    Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boosting the Antibacterial Activity of Azithromycin on Multidrug-Resistant
    Al-Marzooq F; Ghazawi A; Daoud L; Tariq S
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of Action of Isopropoxy Benzene Guanidine against Multidrug-Resistant Pathogens.
    Li J; Zhang X; Han N; Wan P; Zhao F; Xu T; Peng X; Xiong W; Zeng Z
    Microbiol Spectr; 2023 Feb; 11(1):e0346922. PubMed ID: 36475769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Properties of Linezolid, Rifampicin, and Vancomycin, as Well as the Mechanism of Action of Pentamidine, Determine Their Synergy against Gram-Negative Bacteria.
    Tang M; Zhao D; Liu S; Zhang X; Yao Z; Chen H; Zhou C; Zhou T; Xu C
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When Combined with Pentamidine, Originally Ineffective Linezolid Becomes Active in Carbapenem-Resistant Enterobacteriaceae.
    Tang M; Qian C; Zhang X; Liu Y; Pan W; Yao Z; Zeng W; Xu C; Zhou T
    Microbiol Spectr; 2023 Jun; 11(3):e0313822. PubMed ID: 37125928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Non-Antibiotic Drugs Auranofin and Pentamidine in Combination to Combat Multidrug-Resistant Gram-Negative Bacteria.
    Yu Y; Zhao H; Lin J; Li Z; Tian G; Yang YY; Yuan P; Ding X
    Int J Antimicrob Agents; 2022 May; 59(5):106582. PubMed ID: 35378227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens.
    Dillon N; Holland M; Tsunemoto H; Hancock B; Cornax I; Pogliano J; Sakoulas G; Nizet V
    EBioMedicine; 2019 Aug; 46():193-201. PubMed ID: 31353294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flufenamic Acid, a Promising Agent for the Sensitization of Colistin-Resistant Gram-Negative Bacteria to Colistin.
    Zhang Y; Han Y; Wang L; Kong J; Pan W; Zhang X; Chen L; Yao Z; Zhou T; Cao J
    Microbiol Spectr; 2023 Mar; 11(2):e0405222. PubMed ID: 36971552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide Resistance and
    Ma Y; Pirolo M; Subramani P; Gehring R; Damborg P; Franzyk H; Guardabassi L
    mSphere; 2022 Oct; 7(5):e0040222. PubMed ID: 36154672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
    Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bicyclomycin Activity against Multidrug-Resistant Gram-Negative Pathogens.
    Wang W; Zhu X; Luo H; Wang Z; Hong A; Zeng J; Li L; Wang D; Deng X; Zhao X
    Microbiol Spectr; 2023 Feb; 11(1):e0379022. PubMed ID: 36533939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.
    Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergistic antibacterial activity and mechanism of colistin-oxethazaine combination against gram-negative pathogens.
    Li J; Han N; Li Y; Zhao F; Xiong W; Zeng Z
    Front Pharmacol; 2024; 15():1363441. PubMed ID: 38576480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
    Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plantaricin A, Derived from Lactiplantibacillus plantarum, Reduces the Intrinsic Resistance of Gram-Negative Bacteria to Hydrophobic Antibiotics.
    Meng F; Liu Y; Nie T; Tang C; Lyu F; Bie X; Lu Y; Zhao M; Lu Z
    Appl Environ Microbiol; 2022 May; 88(10):e0037122. PubMed ID: 35499329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naringenin restores colistin activation against colistin-resistant gram-negative bacteria
    Xu M; Yao Z; Zhao Y; Shi S; Sun Y; Feng L; Zhou C; Zhang X; Cao J; Zhou T
    Front Microbiol; 2022; 13():916587. PubMed ID: 35992710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discerning the role of polymyxin B nonapeptide in restoring the antibacterial activity of azithromycin against antibiotic-resistant
    Al-Marzooq F; Ghazawi A; Tariq S; Daoud L; Collyns T
    Front Microbiol; 2022; 13():998671. PubMed ID: 36212888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators.
    Baker KR; Jana B; Hansen AM; Vissing KJ; Nielsen HM; Franzyk H; Guardabassi L
    Int J Antimicrob Agents; 2019 Jun; 53(6):868-872. PubMed ID: 30447380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.